Russian specialty pharmaco NovaMedica LLC received exclusive rights to commercialize Spanish firm Venter Pharma SL’s lactose intolerance diagnostic LacTEST in Russia and the CIS. (Dec.)
NovaMedica will perform clinical studies required for gaining approval in the licensed territories, where it expects to launch LacTEST in 2015. Venter Pharma retains rights in the rest of the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?